Cullinan Oncology Statistics
Total Valuation
CGEM has a market cap or net worth of $1.33 billion. The enterprise value is $904.39 million.
Market Cap | 1.33B |
Enterprise Value | 904.39M |
Important Dates
The last earnings date was Wednesday, May 15, 2024, after market close.
Earnings Date | May 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CGEM has 57.63 million shares outstanding. The number of shares has increased by 5.72% in one year.
Shares Outstanding | 57.63M |
Shares Change (YoY) | +5.72% |
Shares Change (QoQ) | +0.47% |
Owned by Insiders (%) | 4.78% |
Owned by Institutions (%) | 78.74% |
Float | 30.92M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 6.30 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.13 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.33, with a Debt / Equity ratio of 0.01.
Current Ratio | 20.33 |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.70% and return on invested capital (ROIC) is -39.95%.
Return on Equity (ROE) | -28.70% |
Return on Assets (ROA) | -27.10% |
Return on Capital (ROIC) | -39.95% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.56M |
Employee Count | 85 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -14.12M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +162.40% in the last 52 weeks. The beta is -0.00, so CGEM's price volatility has been lower than the market average.
Beta (1Y) | -0.00 |
52-Week Price Change | +162.40% |
50-Day Moving Average | 20.06 |
200-Day Moving Average | 13.40 |
Relative Strength Index (RSI) | 48.11 |
Average Volume (30 Days) | 745,382 |
Short Selling Information
The latest short interest is 2.36 million, so 4.09% of the outstanding shares have been sold short.
Short Interest | 2.36M |
Short Previous Month | 1.68M |
Short % of Shares Out | 4.09% |
Short % of Float | 7.62% |
Short Ratio (days to cover) | 2.26 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -171.32M |
Pretax Income | -146.47M |
Net Income | -132.35M |
EBITDA | -146.16M |
EBIT | -146.47M |
Earnings Per Share (EPS) | -$3.13 |
Balance Sheet
The company has $433.01 million in cash and $3.17 million in debt, giving a net cash position of $429.84 million or $7.46 per share.
Cash & Cash Equivalents | 433.01M |
Total Debt | 3.17M |
Net Cash | 429.84M |
Net Cash Per Share | $7.46 |
Equity / Book Value | 425.67M |
Book Value Per Share | 7.39 |
Working Capital | 423.80M |
Cash Flow
In the last 12 months, operating cash flow was -$121.53 million and capital expenditures -$49,000, giving a free cash flow of -$121.57 million.
Operating Cash Flow | -121.53M |
Capital Expenditures | -49,000 |
Free Cash Flow | -121.57M |
FCF Per Share | -$2.83 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CGEM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.72% |
Shareholder Yield | -5.72% |
Earnings Yield | -9.92% |
FCF Yield | -9.11% |
Analyst Forecast
The average price target for CGEM is $32.00, which is 38.11% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $32.00 |
Price Target Difference | 38.11% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -10.14% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |